A chance for US patients to “speak to power”

The roles of patients, patient advocates, and other members of the public in decision-making about the research that is funded by NIH and other agencies here in America is sadly somewhat limited, … READ MORE …

Spontaneous remission in low-risk forms of prostate cancer

The issue of spontaneous remission of low-risk forms of prostate cancer came up yesterday during a meeting of Prostate Cancer International’s Active Surveillance Virtual Support Group (ASVSG). … READ MORE …

Chris Haiman is looking for 10,000 black men (with prostate cancer)!

The RESPOND study, which was initiated in July last year, appears to be the largest-ever study of risk factors for prostate cancer among the African American community, and probably among Black men worldwide. … READ MORE …

No pooping on PCF’s parade, please!

Some 35+ years ago, a guy called Barry Marshall and his colleague Robin Warren discovered that changes to the levels of certain bacteria in the gut led to development of ulcers … and changed everything about the way ulcers are treated. … READ MORE …

UK to invest 75 million in prostate cancer research

According to an announcement on Tuesday from  10 Downing Street in London, Theresa May, the British Prime Minister, has committed to investing £75 million (about US$106 million) in prostate cancer research. … READ MORE …

On active and proactive surveillance

Once upon a time (and not so long ago) newly diagnosed men with some types of prostate cancer used to think your sitemaster was out of his tiny mind when he would suggest to them that they might be wise to just monitor their situation rather than rush into treatment. … READ MORE …

Two leading women talk about the future of treatment of advanced prostate cancer

Nearly 30 years ago, when your sitemaster first attended a prostate cancer meeting (in 1989) related to the upcoming approval of a new drug called flutamide, he doesn’t remember there being a single clinician at the meeting who was female — out of the 150 or so urologists and medical oncologists who had been invited. … READ MORE …